These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 33323948)
1. Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges. Xu ZL; Huang XJ Bone Marrow Transplant; 2021 Apr; 56(4):779-785. PubMed ID: 33323948 [TBL] [Abstract][Full Text] [Related]
2. Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings. Xu ZL; Huang XJ Expert Rev Hematol; 2021 May; 14(5):449-455. PubMed ID: 33945370 [No Abstract] [Full Text] [Related]
3. Comparisons of Modified Post-Transplantation Cyclophosphamide and Granulocyte Colony-Stimulating Factor/Antithymocyte Globulin Regimens for Haploidentical Stem Cell Transplantation in Patients with Aplastic Anemia. Li Y; Lu X; Wang N; Zhang X; Cao Y; Xiao Y; Meng F; Zhang D; You Y; Zou L; Cheng H; Guo J; Zhang Y; Huang Z; Yuan G; Wei J; Wang H; Xia L; Zhang Y Transplant Cell Ther; 2022 Jul; 28(7):396.e1-396.e9. PubMed ID: 35513253 [TBL] [Abstract][Full Text] [Related]
4. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia. Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350 [TBL] [Abstract][Full Text] [Related]
5. Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients. Ma X; Xu Z; Han T; Zhang Y; Han W; Fu H; Zhang X; Lin F; Huang X; Xu L Front Immunol; 2023; 14():1173320. PubMed ID: 37234156 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia]. Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974 [TBL] [Abstract][Full Text] [Related]
7. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study. Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H Front Immunol; 2024; 15():1384640. PubMed ID: 38720904 [TBL] [Abstract][Full Text] [Related]
8. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects. Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Guo ZK; Mao N; Ning HM; Wang HX; Heng Zhu Cytotherapy; 2022 Feb; 24(2):205-212. PubMed ID: 34799271 [TBL] [Abstract][Full Text] [Related]
9. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
10. [Allogeneic hematopoietic stem cell transplantation for patients with aplastic anemia]. Kako S Rinsho Ketsueki; 2020; 61(9):1388-1394. PubMed ID: 33162540 [TBL] [Abstract][Full Text] [Related]
11. A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients. Ding L; Han DM; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Mao N; Guo ZK; Ning HM; Wang HX; Zhu H Stem Cells Transl Med; 2021 Feb; 10(2):291-302. PubMed ID: 32978903 [TBL] [Abstract][Full Text] [Related]
12. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia. Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751 [TBL] [Abstract][Full Text] [Related]
13. Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft- Yao D; Tian Y; Li J; Li B; Lu J; Ling J; Zheng D; Yao Y; Xiao P; Meng L; Hu S Ther Adv Hematol; 2022; 13():20406207221134409. PubMed ID: 36324490 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor. Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223 [TBL] [Abstract][Full Text] [Related]
15. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia. Marsh JCW; Risitano AM; Mufti GJ Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study. Lei M; Zhang Y; Jiao W; Li X; Zhou H; Wang Q; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Liu L; Wu D Front Immunol; 2022; 13():912917. PubMed ID: 35812409 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia. Xu L; Liu Z; Wu Y; Yang X; Cao Y; Li X; Yan B; Li S; Da W; Wu X Eur J Med Res; 2018 Mar; 23(1):12. PubMed ID: 29490698 [TBL] [Abstract][Full Text] [Related]
18. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies. Kang HJ; Hong KT; Lee JW; Kim H; Park KD; Shin HY; Lee SH; Yoo KH; Sung KW; Koo HH; Lee JW; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Jung HJ; Park JE; Lee YH; Lim YT; Lim YJ; Kim SY; Yoo ES; Ryu KH; Lee JH; Park JA; Park SK; Ahn HS; Biol Blood Marrow Transplant; 2016 Aug; 22(8):1455-1459. PubMed ID: 27090956 [TBL] [Abstract][Full Text] [Related]
19. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis. Geng C; Liu X; Chen M; Yang C; Han B Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865 [TBL] [Abstract][Full Text] [Related]
20. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results. Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]